Skip to content

XOMA Corporation XOMA Long-Term Debt

Long-Term Debt at other companies

Royalty Pharma logo
Royalty PharmaRPRX
$8.58B+29.6%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$258.1M+0.6%
Xencor logo
XencorXNCR
$82.12M-19.4%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$42.15B-8.7%
XER
Xeris Biopharma Holdings, Inc.XERS
$221.22M+1.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$745.16M+159%
Enterprise value$784.29M+151%
P/E22×
P/S15.4×+8.6×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's long-term debt?
XOMA Corporation (XOMA) reported long-term debt of $88.83M in Q1 2026.
How has XOMA Corporation's long-term debt changed year-over-year?
XOMA Corporation's long-term debt decreased by 11.1% year-over-year, from $99.93M to $88.83M.
What is the long-term trend for XOMA Corporation's long-term debt?
Over 3 years (2020 to 2025), XOMA Corporation's long-term debt has grown at a 96.2% compound annual growth rate (CAGR), from $12.76M to $96.45M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.